Three novel borosilicate bioactive glasses (BBGs) of general formula of 0.05Na2O0.35x 2 0.20B2O30.40SiO2 (molar ratio, where x = MgO or CaO or SrO) were prepared and used to 3 investigate the effect of crystallisation on their properties including cytotoxicity. The three post-4 melt compositions were determined using X-ray fluorescence spectroscopy and crystallisation 5 events were studied using differential thermal analysis and x-ray diffraction. This information was 6 used to determine heat treatments to prepare glass-ceramics by controlled crystallisation. X-ray 7 diffraction analysis and Fourier transform infrared spectroscopy showed that, after higher heat 8 treatment temperatures (800-900 ºC), borosilicate bioactive glass-ceramics (BBGCs) contained 9 mainly borate and silicate crystalline phases. Specifically, BBG-Mg, BBG-Ca and BBG-Sr glass-10 ceramics detected the presence of magnesium silicate-Mg2(SiO3)2 and magnesium borate-Mg2B2O5; 11 wollastonite-2M-CaSiO3 and calcium borate-Ca(BO2)2; and strontium silicate-SrSiO3 and strontium 12 borate-Sr2B2O5, respectively. In vitro cytotoxicity tests were performed using the mouse fibroblast 13 cell line (L929). Glass and glass ceramic at concentrations lower than 50 mg/ml did not exhibit any 14 level of cytotoxicity when compared with the control. However, quantitative evaluation indicated 15 that greater cell growth occurred in the presence of materials with crystalline phases.
Introduction 1
Bioactive glasses (BGs) and bioactive glass-ceramics (BGCs) have been evaluated for a wide range 2 of clinical applications related to bone tissue repair and regeneration 1 . BGs and BGCs are widely 3 reported to form a bone-like hydroxyapatite (HA) layer on their surface when placed in a simulated 4 biological environment 2 . This has also been demonstrated to occur in vivo 3 . Formation of a bone-5 like HA layer is a fundamental requirement for the establishment of a strong interfacial bond 6 between implants and bone 4 . Since Hench et al. 2 proposed the CaO: SiO2: Na2O: P2O5 system in 7 1969, 45S5 bioglass (or Bioglass ® ) has become the gold standard for this type of material. 8
However, slow degradation rate is a major disadvantage of the silicate based BG, which makes it 9 difficult to match the degradation rate of the BG scaffolds with the rate of new tissue formation 5, 6 . 10
Moreover, some studies with silicate glasses report slow conversion rate to a bone-like HA and 11 often this conversion remains incomplete. Therefore unconverted glass containing SiO2 could 12 remain in human body long after its implantation, raising uncertainty regarding the long-term 13 effects of SiO2 in vivo 7, 8 . 14 The addition of boron oxide to the glass network is one approach that has the potential to overcome 15 the limitations identified above by modifying dissolution rates as well as other properties including 16 tissue bonding 9 . The incorporation of boron in a silicate glass matrix involves lower melting 17 temperatures, with an increased bio-degradation and increased conversion to HA 8, 10, 11 . 18
Furthermore, boron is reported to be beneficial for bone healing and its controlled release stimulates 19 bone formation and maintenance. Frequently, it has been associated with the increase in bone 20 resistance to fractures [12] [13] [14] . Thereby, borosilicate bioactive glasses (BBGs) composition may be 21 used to achieve a more controlled release of specific component ions in order to trigger a range of 22 biological responses 15 . Control of the surface reactions and therefore of the biodegradation and 23 bioactivity of implanted materials can be achieved by varying the chemical nature and/or 24 concentration of the BBGs constituents. For instance, Ciceo Lucacel et al. 16 have used the calcium 1 BBGs doped with silver (Ag + ) to better control Ag + antibacterial properties. Xu et al. 6 have also 2 proposed a sol-gel-derived calcium BBGs system for reinforcing glass-ceramic porous biomaterials 3 and accurately control theirs biodegradability. In another study by Wang et al. 17 , evaluating the of 4 osteogenic properties of BBGs doped with Zinc (Zn 2+ ) these BBGs significantly enhanced bone 5 regeneration in bone defects when implanted into the rats in vivo. Baiano et al. 18 used bioactive 6 glass-based trabecular coating for the development of a novel prosthetic acetabular cup to have an 7 improved in vivo interfacial bond with bone. 8 While studies have been demonstrating the ability of BBGs to better control degradation, thus 9 increasing the beneficial properties of ions release, there are still concerns regarding toxicity when 10 those glasses are implanted 19, 20 . There are several metal ions that at higher concentrations are 11 extremely toxic. In particular, boron release has been associated with cell growth inhibition for 12 concentrations greater then 2.5 mM and also causes cytotoxicity due to release of (BO3) 3-into the 13 medium 12, 19, 20 . Several cellular studies investigated the cytotoxicity of BGs and reported inhibition 14 of cell viability and proliferation for high doses of ions in culture 21, 22 . For instance, Santocildes-15 Romero et al. 23 have showed an increase of the cytotoxic effect of BGs dissolution by increasing 16 the amount of glass powders used and the level of strontium substitution added to the glass 17 for the treatment of osteoporosis 21 . 24 Various studies have been reported concerning the use of heat treatments in order to induce 25 crystallisation in BGs to promote changes in their physico-chemical properties [27] [28] [29] [30] [31] . For instance, 26
Rao et al. 32 have observed improvements in the dielectric constant and less dielectric loss of 1 sodium borosilicate glasses (SiO2 -B2O3-Na2O system) with increase in the duration of the heat 2 treatment. Daguano et al. 27 developed and characterised BGs and BGCs from the CaO-P2O5-SiO2-3
MgO system, using different degrees of crystallinity. They showed that partial crystallisation 4 improved mechanical properties by phase transformation, which modified the microstructure of the 5 base glassy material. Therefore, after studying the thermal profile of BGs, appropriated heat 6 treatment cycle with a controlled temperature increase could be applied to promote the re-7 arrangement of the glass structures generating a well-ordered and crystalline structure. The 8
properties of the formed glass-ceramics are mostly influenced by the characteristics of the finely 9 dispersed crystalline and the residual glassy phases, which can be controlled by the composition of 10 the base glass. However, few authors have reported that the formation of new crystalline phases 11 provoked the modification of toxic effects induced by the glasses in cells 27, 30 . Specially, Hurrell-12
Gillingham et al. 30 investigated the effects of devitrification of glass-ionomer cements (GICs) from 13
SiO2-Al2O3-P2O5-CaO-CaF2 system on glass-ceramic formation and in vitro biocompatibility. They 14 demonstrated that crystallisation might be used to improve the in vitro biocompatibility of GICs. 15 Also Freeman at al. 33 studied the response to implantation of apatite glass-ceramics. They 16 demonstrated that crystallisation significantly improved the bone tissue response. 17 It seems likely that devitrification of glasses represents a route to modify and study their properties 18 including biocompatibility. However, few attempts to modify the biocompatibility of a medical 19 grade glasses using this approach have been reported 30, 33 Aldrich, Australia), silica gel 60M (Macherey-Nagel, Germany), magnesium oxide (Sigma-Aldrich, 5
Portugal) and strontium carbonate (Sigma-Aldrich, Australia). 6
Glass synthesis and preparation 7
The novel BBGs of general formula 0.05Na2O
0.40SiO2 (molar ratio, where x, y = 0.35 or 0.00, and x ≠ y) were synthesised by melt quenching. 9
The appropriate amounts of SiO2, B2O3, NaHCO3, and CaCO3 or MgO or SrCO3 were accurately 10 mixed with ethanol (Sigma, Portugal) in a porcelain pestle and mortar, fully dried overnight and 11 transfer to a platinum crucible. The batch was heated to 1450 ˚C in air for 1 hour and subsequently 12 the melt was quickly poured in a water bath at 4 ˚C to form a glass frit. The glass frit was ground 13 into an Agate mortar (RETSCH, Germany) to obtain microparticles and then, sieved for a size 14 smaller than 63 m. The X-ray fluorescence spectroscopy was used to confirm the glass composition (Philips PW2400 18 X-ray fluorescence spectrometer). Samples were prepared by fusing powdered glass with a known 19 quantity of boron and a flux producing a glass-like bead. After which, they were irradiated with 20 high-energy primary X-ray photons. All the samples were run in triplicate and the percentage (w/w) 21 of the oxides present were determined. Afterwards, molar percentage was calculated for all the 22 samples. The mid point of glass transition (Tg), and crystallisation (Tc) temperatures were determined by 2 differential thermal analysis (Perkin-Elmar DTA7 running Pyris thermal analysis software in Unix) 3 at a heating rate of 10 ºC min -1 from 50 to 1300 ºC. 4
In accordance with DTA data, crystallised glass was prepared for each sample. Briefly, fast-5 quenched particles of the glass samples were heat-treated with a heating rate of 10 ºC min -1 and 6 held for 120 min at each temperature (Tg, Tc1, Tc2 and Tc3) before cooling to room temperature. 7
X-ray diffraction analysis (XRD) and attenuated total reflection Fourier transform 8 infrared (ATR-FTIR) spectroscopy 9
The glasses were analysed before and after each heat treatment by X-ray diffraction analysis (XRD) 10 and attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR). A STOE 11 STADI P X-ray diffractometer was used to identify the crystalline phases. The glass samples were 12 place in aluminium holders and analysed by Cu radiation of wavelength 1.5406 Å at 40 kV and 40 13 mA with a step size of 0.2° in a range of 2 values from 10° to 80° at a scanning speed of 10 s/step. 14 The crystalline patterns were identified by the use of the cards listed in the Joint Commission on 15
Powder Diffraction Standards (JCPDS). The ATR-FTIR spectra were obtained using a Perkin -16 Elmer GX instrument in the range of 4000-550 cm −1 (resolution 4 cm −1 ) for the identification of the 17 chemical bonds present in the glass or glass-ceramic structures. 18
In vitro cytotoxicity 19
The in vitro cytotoxicity study was design following the international guidelines ISO 10993-5:2009 20 34 , using immortalised mouse lung fibroblast-like cell line (L929, Rockville, MD) in indirect contact 21 with glass powders for 3 days. The samples were sterilised in an oven (Gallenkamp Hot Box, 22
England) at 160 °C for 120 min. After sterilisation, the glasses were added to Dulbecco's modified 23
Eagle medium (DMEM, Sigma-Aldrich, UK) solution at a concentration of 0.2 g/mL and incubated 24 for 24 h at 37 °C. After incubation, the glass-conditioned medium was removed and filtered through 1 a 0.2 µm membrane. 2
The L929 cells were expanded in DMEM supplemented with 10 % (v/v) fetal calf serum (Sigma-3 Aldrich, UK), penicillin (100 U/mL, Sigma-Aldrich, UK) and streptomycin (100 g/mL, Sigma-4 Aldrich, UK), and non-essential amino acids (NEAA, Sigma-Aldrich, UK). The L929 cells were 5 cultured at 37 °C in an atmosphere of 5 % CO2. Confluent L929 cells at passages between 15 and 6 19 were harvested and seeded into 48-well culture plates (growth area 0.95 cm 2 ) at a density of 7
2×10
4 cells/well. After a 24 h culture period the culture media was discarded and replaced with 0.5 8 cm 3 of serially diluted, glass-conditioned medium (at a final concentrations of 100, 50, 25, 10, and 5 9 %). L929 cells cultured in the absence of glass particles, was used as negative control and 45S5 10 bioglass-conditioned medium as positive control. After 1 and 3 days time of culturing, the culture 11 medium was removed and the viability and DNA content of the cultures were analysed using 12 PrestoBlue ® and Picogreen ® assays respectively. assay enables measurement of cell proliferation. After each culturing period, the cell monolayers 25 were washed with PBS and then incubated at 37 ºC for 3 h followed by freezing step at -80 ºC for at 1 least over night in ultra-pure water (1 mL) to ensure cell lysis. The assay was performed according 2 to the manufacturer's protocol. And the fluorescence was determined at an excitation wavelength 3 of 485 nm and emission wavelength of 528 nm. The DNA values were normalised to those of the 4 control cultures 5
Morphological evaluation of cell cultures: After each culturing period the cell monolayers were 6 washed with PBS and fixed with 4 % formalin solution (0.5 mL) for 15 min at room temperature 7 (RT). The cell layers were then washed with PBS, containing 0.2 % Triton X, for 2 min. After the 8 fixation and permeation steps, the cell monolayers were washed again with PBS and stained with 9 4,6-diamidino-2-phenyindole dilactate (1:1000 DAPI, Sigma, UK) for 2 min at RT, and phalloidin-10 tetramethylrhodamine B isothiocyanate (Sigma, UK) for 1 h at RT. Finally, the cells were washed 11 and observed using an Axioplan 2 imaging fluorescent microscope with a digital camera QIC AM 12 12-bit (Zeiss, UK). 13
Statistical analysis 14
Experiments were run at least in triplicate for each sample. All data were expressed as mean ± 15 standard deviation (SD). Statistical analysis was determined by using Graphpad Prim ® software, 16 version 6.0. The normality of the data distribution was monitored by Shapiro-Wilk test (p < 0.05). 17
Some of the datasets were not considered to have a normal distribution, requiring a non-parametric 18 statistical evaluation. In this context, Kruskal-Wallis test (p < 0.05) was applied to all dataset, 19
followed by a Dunn's Multiple Comparison test. The X-ray fluorescence data, presented in Table 1 , confirmed that the experimental compositions of 4 bioactive borosilicate glasses obtained by melt-quench method were close to the expected 5 theoretical composition, indicating that the glass network structure was formed as aimed. However, 6 the slight differences between theoretical and XRF data may have been caused by the high volatility 7 of alkali-borate compounds during melting process 35 . 8 Table 1 -X-ray fluorescence spectrometry estimation of elemental concentration (mol %) of BBGs. 
. Differential thermal analysis 12
The DTA was used to study the phase transformation temperatures of the BBGs in order to 13 determine the heat treatment schedule. DTA patterns from all BBGs are presented in Figure 1a . For 14 BBG-Mg and BBG-Sr along with the mid point of glass transition temperature (Tg -endothermic 15 peak), two crystallisation temperatures (Tc -exothermic peaks) were found; while BBG-Ca glasses 16 presented a Tg and one exothermic (Tc1) peak followed by a doublet exothermic peak (Tc2 and Tc3). 17
The
crystallisation temperatures within the range of temperatures of 700 to 900 °C with two phases 2 frequently related with borate and silicate crystal phases 15 . The endothermic peaks are related to 3 the molecular re-arrangement in glass structure preceding and during glass crystallisation, a process 4 known for crystal nucleation and growth 15, 29 . In order to induce crystal nucleus formation in the 5 glass structure, BBGs were kept for 2 hours at Tg and subsequently for 2 hours at each Tc. Each 6
well-defined exothermic peak may result in the formation of a different crystalline phases 28 
The XRD analysis was performed in order to study the crystallinity of the glasses before and after 5 heat treatments and the respective phases formed ( Table 2 ). Figure 2a, 2b and 2c shows the phase 6 evolution XRD patterns of BBG-Mg, -Ca and -Sr glasses, respectively, from amorphous to 7 crystalline phase after the different heat treatment schedules. Heat treatment schedule at Tg were 8 performed and exhibit no significant difference in respect with the as quenched XRD patterns. 9
The XRD patterns of BBG-Mg glass after the first crystallisation heat treatment (BBG-Mg_Tc1) 10 showed a predominantly amorphous phase with weak diffraction peaks, which can be assigned to heat treatment (BBG-Ca_Tc3) the diffraction patterns are comparable to the previous heat treatment 21 patterns (Tc2), which indicates that no detectable amount of different crystalline phase is forming. 22
For the BBG-Sr glass, after the first crystallisation heat treatment (BBG-Sr_Tc1) it was observed a 23 predominant amorphous phase of the glass and a weak diffraction peak, in which the weak peaks 24 can be attributed either to strontium silicate (SrSiO3, JCPDS Card No. 87-474) and/or strontium 1 borate (Sr2B2O5, JCPDS Card No. , suggesting that the formation of crystalline phases 2 starts after the first crystallisation heat treatment. After the second heat treatment (BBG-Sr_Tc2) 3 there were formed two crystalline phases of strontium silicate and strontium borate. 4 Finally, XRD data showed that for all BBGs after heat treatment with lower crystallisation 5 temperatures (Tc1) there was predominantly amorphous with only a small amount crystals 6 formation. However after latter heat treatments (Tc2 and Tc3) occurred the formation of crystalline 7 phases resulting in new silicate and borate glass-ceramics. 8 Figure 2 -X-ray diffraction patterns of phase evolution over increasing crystallisation temperatures 1 for BBG-Mg (a), -Ca (b), -Sr (c) glasses (BBG-ion -before heat treatment, Tc1 -after first heat 2 treatment, Tc2 -after second heat treatment, Tc3 -after third heat treatment). 3
The ATR-FTIR analysis was performed to evaluate the possible changes of vibrational spectra after 4 the heat treatments, because they can induce a process of structural grouping re-arrangements, 5 implying important modifications in the properties of the glasses 30, 36 . ATR-FTIR spectra of BBG-6
Mg, -Ca, -Sr glasses and glass-ceramics are presented in Figure 3a , 3b and 3c, respectively. ATR-7 FTIR spectra of all BBGs consist of dominant broad bands from 740-585 and 1210-740 cm stretching, respectively [37] [38] [39] . The presence of these intense bands indicates the coexistence of 12 silicate and borate bonds, which supports the presence of borosilicate network structure in the 13 amorphous phase. There are two additional less intense bands ranging from 3000 to 2800 and 3750 14 to 3500 cm -1 in all spectra before and after heat treatment, which can be associated with water 15 content. The bands in the range 3000 to 2800 cm -1 have origin in hydrogen bonds and peaks from 16 3750 to 3500 cm -1 are due to OH-groups 36, 40, 41 . Furthermore, there are no significant differences 17 comparing ATR-FTIR spectra of BBGs before and after Tc1 heat treatment (comparing BBG-ion 18 with Tc1 of Figure 3a, 3b and 3c ). This fact suggests that there was no formation of detectable 19 crystalline phases. However, for the latter heat treatments (Tc2 and Tc3) all BBGs showed a splitting 20 of the intense broad bands in several sharp peaks. The splitting of the broad bands might indicate 21 structural grouping re-arrangements (e.g. 1210-740 cm -1 broad band is splitting in 4 different peaks 22
for BBG-Mg glass-ceramic; Figure 3a) . Thus, temperatures higher than 800 °C indeed affected the 23 glass network by rearranging the borosilicate structure. Moreover ATR-FTIR spectra of BBG-Ca 24 glass-ceramics (after Tc2 and Tc3 heat treatment - Figure 3b ) did not show significant differences. 25 This analysis agrees with XRD data, indicating that the crystallisation temperatures of the double 26 exothermic peak found by DTA (Figure 1 ) did not introduce an evident different molecular re-1 arrangement in glass structure and thereby theirs ATR-FTIR spectra will be analysed as one. The 2 correspondent assignments for sharp peaks formed after the latter heat treatments (Tc2 and Tc3) are 3 presented in Figure 3d , from where vibrational peaks ranging from 636-595 and 1270-1010 cm 
In vitro cytotoxicity 6
The cytotoxicity studies were designed to evaluate whether the degradation or dissolution of glasses 7 and glass-ceramics affected the viability and proliferation of mouse lung fibroblast-like cells 8 (L929). The experimental design was based on the international guidelines of ISO 10993-5:2009 9 with some adjustments as described in the methods section 34 . Each glass and glass-ceramic sample 10 was pre-incubated in DMEM to give a glass-conditioned media that were added to the cell cultures 11 for 1 and 3 days. 12
The PrestoBlue ® viability data (Figure 4) showed that L929 cells in the presence either of glass-or 1 glass-ceramic-conditioned medium exhibited a metabolic activity higher than 50% for 2 concentrations lower than 50 mg/mL. In the case of BBG-Mg glass and glass-ceramics even after 3 3 days of culture, the cells displayed good metabolic activity for media conditioned by concentrations 4 of 50 mg/mL (e.g.: for BBG-Mg_ Tc2 at 50 mg/mL concentration, cells present 74 % of metabolic 5 activity). However, all BBGs before and after heat treatment showed far higher metabolic activity 6 than the commercial 45S5 bioglass (e.g.: after 3 days of culture with 45S5 bioglass-conditioned 7 media, L929 cells showed only 1% of the metabolic activity observed in the control cultures). 8 Figure 5 exhibits the DNA measurements of L929 culture normalized to the control cultures 9 incubated in culture medium only. For all BBGs, before and after heat treatment, concentrations 10 below 50 mg/mL showed DNA levels indicating cell proliferation rates close to 100%, meaning that 11 the conditioned medium was not affecting cell proliferation. Similarly to the results observed in the 12 cell viability assays, BBG-Mg glass or glass-ceramics exhibited less cytotoxic effects than BBG-Ca 13 and -Sr glasses and glass-ceramics. Higher proliferation rates were observed with the media 14 conditioned with BBG-Mg than for the BBG-Ca or BBG-Sr-conditioned media ( Figure 5) . 15 Furthermore, culture medium conditioned by 45S5 bioglass was found to be significantly more 16 cytotoxic than culture medium conditioned with BBG glasses and glass-ceramics. Crystallisation of 17 the glasses was found to have no significant effect on cellular behaviour at day 1 however at day 3, 18 different cellular behaviour profiles were observed at all the concentrations tested. Specifically, for 19 the BBG-Mg glasses, an increase in cytotoxicity was detected for the first heat-treated glass-20 ceramics (Tc1), which could be related to the formation of SiO2 during the heat treatment. The 21 formation of SiO2 molecules reduces the amount of silicate in the dominant amorphous phase, 22 which may increase the ratio of borate in the amorphous glass matrix. The borate-rich amorphous 23 phase has a faster degradation rate 15 , increasing the quantity of ions in solution as well as the pH (~ 24 8.0-9.0) 46 . On the other hand, the BBG-Mg glass-ceramics formed after the second heat treatment 25 (Tc2) showed a reduction in cytotoxic, which may have been due to the formation of two different 26 crystalline phases (magnesium silicate and magnesium borate) so reducing the availability of ions 1 contained largely within the stable crystalline phases 27, 30 . 2
The glass-ceramics produced from heat-treated BBG-Ca and -Sr glasses also showed different 3 cellular behaviour from the parent glasses. A reduction in cytotoxicity was found for glass-ceramics 4 formed after the first heat treatment (Tc1) and an increase in cytotoxicity with further heat 5 treatments (Tc2 and Tc3). These results may be explained by the formation of different crystalline 6 phases with higher availability for ion release, which may have increased the pH and can be directly 7 observed by colour changes in medium culture 30 . The pH of the non-conditioned and conditioned 8 media was measured and found to range from 8.0 to 8.5 for all BBG glasses and glass ceramics. 9
The pH of conditioned media from 45S5 bioglass ranged between 8.5 and 9. While the addition of 10 boron to glass matrix is associated with bone healing and formation as well higher conversion rates 11 to HA 6, 12 ; the cytotoxic evaluation demonstrated that it is possible to modify the cytotoxic effects 12 of BBGs by a controlled crystallisation of the constituent glasses. Together, these features make 13
BBGs suitable candidates for bone tissue engineering application. 14 Specifically, for the BBG-Mg glasses, an increase in cytotoxicity was detected for the first heat-23 treated glass-ceramics (Tc1), which could be related to the formation of SiO2 during the heat 24 treatment. The formation of SiO2 molecules reduces the amount of silicate in the dominant 25 amorphous phase, which may increase the ratio of borate in the amorphous glass matrix. The 26 borate-rich amorphous phase has a faster degradation rate 15 , increasing the quantity of ions in 1 solution as well as the pH (~ 8.0-9.0) 46 . On the other hand, the BBG-Mg glass-ceramics formed 2 after the second heat treatment (Tc2) showed a reduction in cytotoxic, which may have been due to 3 the formation of two different crystalline phases (magnesium silicate and magnesium borate) so 4 reducing the availability of ions contained largely within the stable crystalline phases 27, 30 . 5
The glass-ceramics produced from heat-treated BBG-Ca and -Sr glasses also showed different 6 cellular behaviour from the parent glasses. A reduction in cytotoxicity was found for glass-ceramics 7 formed after the first heat treatment (Tc1) and an increase in cytotoxicity with further heat 8 treatments (Tc2 and Tc3). These results may be explained by the formation of different crystalline 9 phases with higher availability for ion release, which may have increased the pH and can be directly 10 observed by colour changes in the culture medium 30 . The pH of the non-conditioned and 11 conditioned media was measured and found to range from 8.0 to 8.5 for all BBG glasses and glass 12 ceramics. The pH of conditioned media from 45S5 bioglass ranged between 8.5 and 9.0. 13 1 Figure 6 -Fluorescence microscopy of L929 cells morphology after 3 days incubation with BBGs 1 or BBGCs -conditioned media. Conditioned media were prepared with 10 mg/ml, 50 mg/ml or 200 2 mg/ml BBG glass or BBGCs. Cells cultured with non-conditioned medium was used as negative 3 control and 45S5 bioglass conditioned media was used as positive control (The blue colour (DAPI 4 staining) shows the nucleus of cells; Green colour (phalloidin staining) shows the actin filaments). 5
Conclusions 6
Three novel amorphous BBGs with different glass modifiers have been successfully synthesised by 7 the melt quench technique. The DTA analysis allowed the identification of two or more exothermic 8 peaks indicative of crystallisation. However, after a controlled heat treatment at these temperatures, 9
XRD and ATR-FTIR data indicated that only the samples that were treated at the higher 10 crystallisation temperatures produced significant crystalline phase(s). Also, different crystalline 11 phases were formed for the different substituted BBGs. Specifically for, BBG-Mg, BBG-Ca and 12 BBG-Sr glass-ceramics was detected the presence of magnesium silicate-Mg2(SiO3)2 and 13 magnesium borate-Mg2B2O5; wollastonite-2M-CaSiO3 and calcium borate-Ca(BO2)2; and strontium 14 silicate-SrSiO3 and strontium borate-Sr2B2O5, respectively. To our knowledge, this is the first time 15 it is demonstrated that controlled crystallisation of BBGs might produce glass-ceramics with less 16 cytotoxic effects on cells. Moreover, neither BBGs nor BBGCs induced a cytotoxic effect on cells 17 at concentrations lower than 50 mg/mL and they exhibited less cytotoxicity compared to 45S5 18 bioglass at all concentrations used. Finally, interaction of BBGs with cells in a biological 19 environment is a complex process that is continuously under study from the scientific and medical 20 device communities. However, the great biodegradable properties of BBGs combined with the fact 21 that partial or total crystallisation permits cytotoxicity reduction. The BBGs can be used to achieve 22 medical-grade material for development of new generation bone tissue engineered implants. 23
